| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.096 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |